145 related articles for article (PubMed ID: 2200536)
1. High-dose melphalan and granulocyte-macrophage colony-stimulating factor for refractory multiple myeloma.
Barlogie B; Jagannath S; Dixon DO; Cheson B; Smallwood L; Hendrickson A; Purvis JD; Bonnem E; Alexanian R
Blood; 1990 Aug; 76(4):677-80. PubMed ID: 2200536
[TBL] [Abstract][Full Text] [Related]
2. Low-risk intensive therapy for multiple myeloma with combined autologous bone marrow and blood stem cell support.
Jagannath S; Vesole DH; Glenn L; Crowley J; Barlogie B
Blood; 1992 Oct; 80(7):1666-72. PubMed ID: 1391937
[TBL] [Abstract][Full Text] [Related]
3. G-CSF is a major component of colony-stimulating activity (CSA) in the plasma of patients with multiple myeloma after treatment with high-dose melphalan (HDM).
Joffe JK; Bell JB; Denham S; Adshead F; Millar JL; Millar BC
Exp Hematol; 1995 Apr; 23(4):376-82. PubMed ID: 7534716
[TBL] [Abstract][Full Text] [Related]
4. Granulocyte-macrophage colony stimulating factor (GM-CSF) after high-dose melphalan in patients with advanced colon cancer.
Steward WP; Scarffe JH; Dirix LY; Chang J; Radford JA; Bonnem E; Crowther D
Br J Cancer; 1990 May; 61(5):749-54. PubMed ID: 1692472
[TBL] [Abstract][Full Text] [Related]
5. Prospective randomized placebo-controlled study of granulocyte-macrophage colony-stimulating factor without stem-cell transplantation after high-dose melphalan in patients with multiple myeloma.
Moreau P; Fiere D; Bezwoda WR; Facon T; Attal M; Laporte JP; Colombat P; Haak HL; Monconduit M; Lockhorst H; Girault D; Harousseau JL
J Clin Oncol; 1997 Feb; 15(2):660-6. PubMed ID: 9053491
[TBL] [Abstract][Full Text] [Related]
6. Clinical experience with recombinant human granulocyte colony-stimulating factor and granulocyte macrophage colony-stimulating factor.
Morstyn G; Lieschke GJ; Sheridan W; Layton J; Cebon J; Fox RM
Semin Hematol; 1989 Apr; 26(2 Suppl 2):9-13. PubMed ID: 2471275
[TBL] [Abstract][Full Text] [Related]
7. Colony stimulating activity in the serum of patients with multiple myeloma is enhanced by interleukin 3: a possible role for interleukin 3 after high dose melphalan and autologous bone marrow transplantation for multiple myeloma.
Millar BC; Bell JB; Montes A; Millar JL; Maitland JA; Treleaven J; Viner C; Gore M; McElwain TJ
Br J Haematol; 1990 Jul; 75(3):366-72. PubMed ID: 2201402
[TBL] [Abstract][Full Text] [Related]
8. Stimulation of myelopoiesis in a patient with congenital neutropenia: biology and nature of response to recombinant human granulocyte-macrophage colony-stimulating factor.
Vadhan-Raj S; Jeha SS; Buescher S; LeMaistre A; Yee G; Lu L; Lloreta J; Hoots WK; Hittelman WN; Gutterman JU
Blood; 1990 Feb; 75(4):858-64. PubMed ID: 2405922
[TBL] [Abstract][Full Text] [Related]
9. Stimulation of nonclonal hematopoiesis and suppression of the neoplastic clone after treatment with recombinant human granulocyte-macrophage colony-stimulating factor in a patient with therapy-related myelodysplastic syndrome.
Vadhan-Raj S; Broxmeyer HE; Spitzer G; LeMaistre A; Hultman S; Ventura G; Tigaud JD; Cork MA; Trujillo JM; Gutterman JU
Blood; 1989 Oct; 74(5):1491-8. PubMed ID: 2676013
[TBL] [Abstract][Full Text] [Related]
10. Subcutaneous recombinant granulocyte-macrophage colony-stimulating factor used as a single agent and in an alternating regimen with azidothymidine in leukopenic patients with severe human immunodeficiency virus infection.
Pluda JM; Yarchoan R; Smith PD; McAtee N; Shay LE; Oette D; Maha M; Wahl SM; Myers CE; Broder S
Blood; 1990 Aug; 76(3):463-72. PubMed ID: 2198957
[TBL] [Abstract][Full Text] [Related]
11. Peripheral blood stem cell transplants for multiple myeloma: identification of favorable variables for rapid engraftment in 225 patients.
Tricot G; Jagannath S; Vesole D; Nelson J; Tindle S; Miller L; Cheson B; Crowley J; Barlogie B
Blood; 1995 Jan; 85(2):588-96. PubMed ID: 7529066
[TBL] [Abstract][Full Text] [Related]
12. Effect in vivo of recombinant GM-CSF on neutropenia and survival in mice treated by high-dose melphalan.
Sagi O; Witz IP; Shaked N; Ramot B; Douer D
Eur J Haematol; 1989 Sep; 43(3):240-4. PubMed ID: 2680579
[TBL] [Abstract][Full Text] [Related]
13. Growth factor-assisted chemotherapy--the Manchester experience.
Crowther D; Scarffe JH; Howell A; Thatcher N; Bronchud M; Steward WP; Testa N; Dexter M
Ciba Found Symp; 1990; 148():201-10; discussion 211-4. PubMed ID: 1690624
[TBL] [Abstract][Full Text] [Related]
14. Clinical studies with recombinant human granulocyte-macrophage colony-stimulating factor.
Steward WP; Scarffe JH; Bonnem E; Crowther D
Int J Cell Cloning; 1990 Jan; 8 Suppl 1():335-46. PubMed ID: 2182743
[TBL] [Abstract][Full Text] [Related]
15. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.
Arora M; Burns LJ; Barker JN; Miller JS; Defor TE; Olujohungbe AB; Weisdorf DJ
Biol Blood Marrow Transplant; 2004 Jun; 10(6):395-404. PubMed ID: 15148493
[TBL] [Abstract][Full Text] [Related]
16. Serum colony stimulating factors in patients undergoing bone marrow transplantation: enhancing effect of recombinant human GM-CSF.
Geissler D; Niederwieser D; Aulitzky WE; Tilg H; Grünewald K; Huber C; Konwalinka G
Behring Inst Mitt; 1988 Aug; (83):289-300. PubMed ID: 3071343
[TBL] [Abstract][Full Text] [Related]
17. Stimulation of hematopoiesis in patients with bone marrow failure and in patients with malignancy by recombinant human granulocyte-macrophage colony-stimulating factor.
Vadhan-Raj S; Buescher S; LeMaistre A; Keating M; Walters R; Ventura C; Hittelman W; Broxmeyer HE; Gutterman JU
Blood; 1988 Jul; 72(1):134-41. PubMed ID: 3291976
[TBL] [Abstract][Full Text] [Related]
18. Hematopoietic recovery following high-dose combined alkylating-agent chemotherapy and autologous bone marrow support in patients in phase-I clinical trials of colony-stimulating factors: G-CSF, GM-CSF, IL-1, IL-2, M-CSF.
Laughlin MJ; Kirkpatrick G; Sabiston N; Peters W; Kurtzberg J
Ann Hematol; 1993 Dec; 67(6):267-76. PubMed ID: 7506580
[TBL] [Abstract][Full Text] [Related]
19. Granulocyte colony-stimulating factor stimulates recovery of granulocytes in patients receiving dose-intensive chemotherapy without bone marrow transplantation.
Neidhart J; Mangalik A; Kohler W; Stidley C; Saiki J; Duncan P; Souza L; Downing M
J Clin Oncol; 1989 Nov; 7(11):1685-92. PubMed ID: 2478670
[TBL] [Abstract][Full Text] [Related]
20. Granulocyte-macrophage colony-stimulating factor (GM-CSF) priming of high-dose etoposide and cyclophosphamide: a pilot trial.
Bernstein SH; Christiansen NP; Fay JP; Brown R; Herzig R; Frankel S; Blumenson L; Herzig GP
Exp Hematol; 1996 Oct; 24(12):1363-8. PubMed ID: 8913281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
